Cardiac Stress Test Procedure Note/Interpretation

Patient name: [Patient name] MRN: [MRN] DOB: [DOB] Age: [Age] Sex: [Sex] (If any identifier is unavailable, write 'not available in report view'.)
Date of service: [Date of service] Start time: [Start time]
Location/lab: [Location/lab]
Ordering clinician: [Ordering clinician]
Interpreting clinician: [Interpreting clinician and credentials]
Test type: [Exercise treadmill stress ECG / Exercise stress with nuclear tracer injection / Pharmacologic vasodilator stress with or without low-level exercise / Dobutamine stress]
Comparison: [Prior stress test dates and modalities] (If none, state 'no prior study available'.)

Indication and Clinical Context

[Primary indication in clinical language] [Relevant clinical context affecting interpretation: known CAD, prior MI/PCI/CABG, heart failure, valvular disease, pertinent risk factors] [Rate-limiting or anti-ischemic medications taken day of test and whether held] (If indication is not available from the order, state 'indication not available from order'; do not infer.)

Stress Protocol

[Stress modality used] (Include the appropriate protocol elements below based on modality; use only the applicable section.)

• If exercise: [Protocol name (Bruce / Modified Bruce / Ramp / other)], [Exercise duration mm:ss], [Peak workload in METs], [Reason for termination: fatigue / dyspnea / chest pain / arrhythmia / target achieved / other] (Do not list target HR alone as the sole reason. If any item is unavailable, write 'not available in report view'.)
• If pharmacologic: [Agent and dose/route (e.g., regadenoson bolus dose; adenosine infusion rate and duration; dobutamine staged doses with peak dose)], [Adjuncts used: low-level exercise / atropine total dose / aminophylline reversal / none], [Timing of tracer injection relative to stress], [Reason for termination] (If dosing details are unavailable, state 'dosing details not available in report view'.)
• Recovery monitoring: [Recovery duration and monitoring details] (Include if documented.)

Baseline Findings

• Resting vitals: [Resting heart rate] bpm, [Resting blood pressure] mmHg (If unavailable, state 'not available in report view'.)
• Resting ECG summary: [Rhythm], [Conduction abnormalities if present], [Baseline ST-T abnormalities if present]
• ECG interpretability for ischemia: [Interpretable / Not interpretable] (If not interpretable, specify why: LBBB / ventricular pacing / >1 mm resting ST depression / WPW / other. This statement is required.)

Stress Response

• Peak hemodynamics: [Peak heart rate] bpm ([Percent of maximum predicted HR achieved]%), [Peak blood pressure] mmHg, [Rate-pressure product if available] (If any value is unavailable, state 'not available in report view'.)
• Blood pressure response: [normal / hypertensive / hypotensive / blunted] (Document characterization.)
• Symptoms during stress and recovery: [Chest pain with typicality and timing / dyspnea / dizziness / leg fatigue / none] (If asymptomatic, explicitly state 'no chest pain and no limiting symptoms'.)
• Arrhythmias: [Type, timing of onset, and clinical significance] (If none, state 'no arrhythmias observed'.)
• ST-segment changes: [Direction (upsloping / horizontal / downsloping), magnitude in mm, leads involved, timing of onset by stage or time, persistence into recovery and duration] (If no ischemic changes, state 'no significant ST-segment changes'.)
• Overall ECG result: [negative / positive / equivocal / uninterpretable] (If equivocal or uninterpretable, specify the limiting factor.)

Adequacy and Technical Quality

[Adequate / Not adequate for diagnostic purposes] (If not adequate, document the reason: submaximal HR due to fatigue / beta-blocker effect / early termination for safety / orthopedic limitation / other. Note any technical limitations affecting interpretation.)

Imaging Linkage

(Include only when applicable; omit entire section if no imaging performed.)

• Radiotracer timing: [Tracer injection timing relative to peak stress]
• Imaging interpretation: [Myocardial perfusion imaging / Stress echocardiography] interpretation [is reported separately / is included here]
• Discordance: [Document any known discordance between stress ECG findings and imaging results] (Include only if discordance present.)

Interpretation

[Concise clinical synthesis addressing exercise capacity and prognostic implication, hemodynamic response abnormalities, symptom reproduction and concordance with ECG findings, arrhythmia significance, and ECG ischemia conclusion] (Include Duke Treadmill Score or heart rate recovery only if routinely calculated by the lab and explicitly available.)

Impression

1. [Overall test result including adequacy and ECG conclusion: negative / positive / equivocal / uninterpretable for ischemia]
2. [Risk characterization based on workload, hemodynamic response, ECG changes, symptoms, and arrhythmias]
3. [Actionable recommendation aligned to the result: routine follow-up / expedited cardiology evaluation / anatomic testing / alternative modality due to nondiagnostic test; specify limitation if applicable]
4. [Additional recommendation if applicable] (Limit to two to four total items.)

Adverse Events and Disposition

(Include only if adverse events occurred; otherwise omit entire section.)

• Event: [Adverse event description]
• Treatment: [Treatment given including medications and doses]
• Disposition: [Observation / transfer / discharge]
• Communication: [To whom critical results were communicated and timing]

Interpreting clinician signature: [Name, credentials, and signature]
Date/time signed: [Date and time]